← Back to Search

Patient Group for High Blood Pressure

N/A
Waitlist Available
Led By Keith Ferdinand, MD
Research Sponsored by Tulane University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 2 months
Awards & highlights

Study Summary

This study is evaluating whether a set of text messages can improve medication adherence in people with hypertension.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 2 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 2 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Measure of Quality of Life Assessed by 14-item Center for Disease Control (CDC) Health Related Quality of Life Questioner
Secondary outcome measures
Change in Systolic and Diastolic Blood Pressure Done by Investigators
Change in Systolic and Diastolic Blood Pressure Done by the Participant
Self-report Adherence to Medication

Trial Design

1Treatment groups
Experimental Treatment
Group I: Patient GroupExperimental Treatment1 Intervention
Participants will be enrolled in a bidirectional text messaging system from Tulane University Medical Group where they will receive and send text from their mobile phones to monitor their anti-hypertension medication regimen. Text messages will be sent: daily for medication and refill reminders; weekly for hypertension education messages and asking if a support person helped them with medication reminders. Study personnel will educate participants on proper blood pressure technique to conduct self-measured blood pressure (SMBP) at home. These blood pressure values will be automatically uploaded twice daily from a Bluetooth device to a phone application to allow the participant and healthcare team track their blood pressure. Participants will receive the Bluetooth blood pressure device to perform SMBP at enrollment.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Text
2022
N/A
~5500

Find a Location

Who is running the clinical trial?

National Institute of General Medical Sciences (NIGMS)NIH
269 Previous Clinical Trials
247,076 Total Patients Enrolled
Tulane UniversityLead Sponsor
115 Previous Clinical Trials
226,466 Total Patients Enrolled
LA CaTS Clinical Research Resources CoreUNKNOWN

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Text My Hypertension BP Meds NOLA
2022. "Text My Hypertension BP Meds NOLA". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05074173.
~12 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top